Filed by Soaring Eagle Acquisition Corp. pursuant to
Rule 425 under the Securities Act of 1933
and deemed filed pursuant to Rule 14a-12
under the Securities Exchange Act of 1934
Subject Company: Ginkgo Bioworks, Inc.
Commission File No.: 333-256121
Ginkgo Bioworks Announces Date of First Half 2021 Results Presentation
Presentation and Q&A session scheduled for Wednesday, August 18, 2021
BOSTONAug. 9, 2021Ginkgo Bioworks, Inc. (Ginkgo), which recently announced a business combination with Soaring Eagle
Acquisition Corp. (Nasdaq: SRNG), announced that it will host a presentation reviewing results for the first six months of 2021 after the market closes on Wednesday, August 18, 2021, beginning at 4:30 p.m. ET. The presentation will include an
overview of first half performance, recent updates, and a discussion on Ginkgos business model and outlook.
The presentation details and
registration link will be available on Ginkgos investor relations website at www.ginkgobioworks.com/investors and a replay will be made available.
To ask a question ahead of the presentation, please submit them to @Ginkgo on Twitter (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.
About Ginkgo Bioworks
Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The companys platform is enabling biotechnology
applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo is also actively supporting a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization and therapeutics discovery. In May 2021, Ginkgo announced a business combination with Soaring Eagle Acquisition Corp. (Nasdaq: SRNG), which, if completed, will
result in Ginkgo, through a parent entity, Ginkgo Bioworks Holdings, Inc., becoming a public company. The transaction is expected to close in the third quarter of 2021, subject to regulatory and shareholder approvals, and other customary closing
conditions. For more information, visit www.ginkgobioworks.com.
ADDITIONAL LEGAL INFORMATION
Forward-Looking Statements Legend
This document contains
certain forward-looking statements within the meaning of the federal securities laws with respect to the proposed transaction between Ginkgo and Soaring Eagle Acquisition Corp. (SRNG), including statements regarding the benefits of the
transaction, the anticipated timing of the transaction, the services offered by Ginkgo and the markets in which it operates, and Ginkgos projected future results. These forward-looking statements generally are identified by the words
believe, project, expect, anticipate, estimate, intend, strategy, future, opportunity, plan, may, should,
will, would, will be, will continue, will likely result, and similar expressions. Forward-looking statements are predictions, projections and